An electronic nose using machine learning can detect early signs of ovarian cancer in blood samples with 97 per cent accuracy, according to researchers. The device...
Researchers have secured A$2.8m to test whether AI can better predict ovarian cancer survival and response to treatment. The grant will allow researchers to use AI...
Agilent has FDA approval for a test to identify ovarian cancer patients who may be eligible for immunotherapy. Agilent’s PD-L1 IHC 22C3 pharmDx is the only...
A surgical procedure developed in Canada reduces the risk of the most common and deadly form of ovarian cancer by nearly 80 per cent. The strategy,...
The National Institute for Health and Care Excellence (NICE) has proposed age-based thresholds for ovarian cancer screening to help identify women at higher risk earlier. Previously,...
Analysis of fluid flushed through a fallopian tube holds promise for providing insights into molecular changes linked to early ovarian cancer development, new research has revealed....
A combination of THC and CBD derived from cannabis was shown to kill ovarian cancer cells without harming healthy cells in laboratory studies. The findings suggest...
Femtech World explores the latest research developments in the world of women’s health. Fertility treatments linked to higher mutations than natural conception Mice that were conceived...
High-risk women can now delay ovary removal surgery through NHS screening, helping them preserve fertility and avoid early surgical menopause. The ROCA test tracks women with...
AbbVie said on Monday that it will launch ovarian cancer drug Elahere in the UK at the same list price as in the US. The announcement...
